Thomas Anthony Guerriero, CEO of Oxford City Football Club, Inc. (OTCQB:OXFC), Names World Leading Cardiologist & Founder of Placidus Medical Dr. Yoseph Shalev To Their Advisory Board

Yoseph Shalev, M.D., F.A.C.C., founder of Placidus Medical, is officially named into the advisory board of Oxford City Football Club (OTCQB:OXFC) and plans to lead a research & development team at Oxford City University in South Florida to work on advancements in Cardiology.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dr. Yoseph Shalev

I am delighted to join the Advisory Board at Oxford City Football Club, Inc. I look forward to being part of the journey and cementing my mark in Oxford City FC history.

Deerfield Beach, FL (PRWEB) September 19, 2013

Thomas Anthony Guerriero, CEO of Oxford City Football Club (OTCQB:OXFC) officially names Dr. Yoseph Shalev to their Advisory Board. “The addition of Dr. Yoseph Shalev to Oxford City’s Board will bring a wealth of experience to the Board. He is a true visionary and innovator and we expect him to bring a real added value to the company,” said Thomas Anthony Guerriero, CEO.

Yoseph Shalev, MD, is currently Section Head of Cardiology for Wheaton Franciscan Health Care in St. Jospeh’s Hospital, Milwaukee, WI. A primary investigator for national and international grant-funded studies and co-investigator for many others. He lectures frequently on advances in managing congestive heart failure and acute ischemic syndromes. Dr. Yoseph Shalev is a reviewer for Sports Medicine, Catheterization and Cardiovascular Diagnosis, and Journal of the American College of Cardiology. He has published original articles and presented abstracts at scientific meetings of the American College of Cardiology and the American Heart Association, as well as abroad.

Board certified in Cardiology, Interventional Cardiology and Internal Medicine, Dr. Shalev has also been Clinical Adjunct Associate Professor, Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Aurora Sinai/Aurora St. Luke’s Medical Canters, in Milwaukee, Wisconsin.

Dr. Shalev holds an M.D. Degree from School of Medicine of the Hebrew University, Hadassah, Jerusalem in 1973. He completed an internship from 1973 to 1974 at Kaplan Hospital, Rehovot, Israel. He has a fellow in Cardiology, Clinical Cardiology and Interventional Cardiology from Kaplan Hospital, Rehovot, Israel, and University of Wisconsin Medical School (Milwaukee Clinical Campus), Sinai Samaritan Medical Center, Milwaukee, Wisconsin from 1984 to 1990.

“I am delighted to join the Advisory Board at Oxford City Football Club, Inc.,” said Dr. Shalev. “I look forward to being part of the journey and cementing my mark in Oxford City FC history.”

About Oxford City FC
Oxford City Football Club (http://www.oxfordcityfc.com) is a publicly traded company with short term plans to go to the AMEX/NYSE, which is an owner of two professional football clubs. Oxford City, Inc. has one club which plays in the Conference North Division and another, which plays in the Hellenic League Premier Division. Both clubs are members of the English Football Association.

The company is strategically positioned to implement their vertical integration model incorporating all their divisions towards future growth. The company also owns Oxford City University (http://www.oxfordcityuniversity.org) in the United States, which expects to have its first brick and mortar campus offering their comprehensive professional degree programs in South Florida in the near future. OXFC expects the strong ties in Oxford where they own Oxford City Sports College, to strategically put the University in a tremendous position for the future. The company also owns a Registered Investment Advisory Firm based in South Florida. This diversified portfolio of companies has established a solid core foundation, which we hope will allow the company to have a multitude of revenue streams in the future.

Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21B of the Securities and Exchange Act of 1934, as amended. Readers are cautioned not place undue reliance on these forward-looking statements, which are only predictions and only speak as of the date hereof. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "plan," "expect," or similar expressions and are subject to numerous known and unknown risks and uncertainties. These risks and uncertainties could cause the Company's actual results to differ materially those indicated in the forward-looking statements. Investors are encouraged to carefully review regulatory filings prior to investment consideration. Past performance is no guarantee of future success or that there cannot be losses or business interruption. The Company is in a rapid growth sector that may or may not continue to grow in the future and therefore poses risks that may be different than other investments. Management regularly provides news and additional information believed to be true and accurate at the time of dissemination but has no requirement to modify, comment or change in the future should circumstance change or information prove to be inaccurate for any reason. Additionally, the Company makes every effort to comply with all applicable laws.


Contact